() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: MO

Lexaria Bioscience Announces Partnership with Altria to Fund Research and Development of DehydraTECH(tm) Technology for Oral Nicotine

January 15, 2019 - Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) ( "Lexaria Bioscience"), a drug delivery platform innovator, is pleased to announce that its wholly-owned subsidiary Lexaria Nicotine LLC ("Lexaria Nicotine") and Altria Ventures Inc., an indirect wholly owned subsidiary of Altria Group, Inc. (NYSE:MO) ("Altria"), have executed definitive agreements to pursue innovation in oral, reduced risk nicotine consumer products using Lexaria's patented DehydraTECH(TM) technology.
Read more